Skip to content

Efficacy of Corticosteroid Injection Into Coracohumeral Ligament in Patients With Adhesive Capsulitis of the Shoulder

Efficacy of Corticosteroid Injection Into Coracohumeral Ligament in Patients With Adhesive Capsulitis of the Shoulder

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03013205
Enrollment
60
Registered
2017-01-06
Start date
2017-02-28
Completion date
2018-10-31
Last updated
2017-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Direct Coracohumeral Ligament Steroid Injection

Keywords

adhesive capsulitis

Brief summary

Steroid injections are widely utilized to reduce inflammation and fibrosis in patients with the frozen shoulder. In this study, investigators will compare intra-articular steroid injections with direct coracohumeral ligament steroid injection to conventional intra-articular steroid injection. Investigators will measure the primary outcome as shoulder function improvement and secondary outcomes as ROM, pain scale and stiffness of coracohumeral ligament under elastogram.

Detailed description

Adhesive capsulitis of the shoulder, also known as the frozen shoulder, often leads to severe pain and shoulder range of motion limitation. Steroid injections are widely utilized to reduce inflammation and fibrosis. The thickening of the coracohumeral ligament was thought to play an important role in the pathogenesis of frozen shoulder, resulting in limited external rotation of the shoulder. While the elastogram of coracohumeral ligament will significantly increase stiffness under the shear-wave ultrasound (shear-wave elastography). Therefore, in this study, investigators will compare intra-articular steroid injections with direct coracohumeral ligament steroid injection to conventional intra-articular steroid injection. Investigators will measure the primary outcome as shoulder function improvement and secondary outcomes as ROM, pain scale and stiffness of coracohumeral ligament under elastogram. (the patient will not have additional risk of injection under ultrasound guidance)

Interventions

PROCEDUREIntraarticular triamcinolone injection

triamcinolone 10mg/mL

PROCEDUREIntraarticular Xylocaine injection

Xylocaine 1% 4ml

PROCEDURECoracohumeral ligament triamcinolone injection

triamcinolone 10mg/mL

PROCEDUREPhysiotherapy

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

A.Inclusion criteria: 1. Age 20-80 years old 2. Unilateral shoulder pain more than 3 months 3. At least one shoulder ROM limitation in three dimensions which decreased over 50% (Abduction, Flexion, External rotation) 4. Visual analog scale more than 30 (total 100) 5. No fracture or subluxation or arthritis in shoulder Xray. B.

Exclusion criteria

: 1. History of shoulder or chest surgery 2. History of shoulder trauma in 2 recent years 3. Ever receiving shoulder joint injection in recent 3 months 4. With cervical radiculopathy or any central CNS disorders 5. With osteoarthritis or rheumatic arthritis of shoulder 6. Diagnosed as rotator cuff tear, tendon calcification or bursitis 7. Systemic diseases including diabetes or thyroid disorder 8. Allergy history of steroid

Design outcomes

Primary

MeasureTime frameDescription
Shoulder function (The Disabilities of the Arm, Shoulder and Hand Score, QuickDash) improvement2 yearsshoulder function improvement (The Disabilities of the Arm, Shoulder and Hand Score, QuickDash), score 0-100

Secondary

MeasureTime frameDescription
Change of Visual analogue scale2 yearsVisual analogue scale: scale 0-10
Shoulder range of motion improvement2 yearsRange of motion improvement: flexion, abduction, external rotation (degree)
Stiffness of coracohumeral ligament under elastogram (KPa)2 years

Countries

Taiwan

Contacts

Primary ContactChueh-Hung Wu
nojred@gmail.com0972651208

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026